Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer.
about
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.Function of RasGRP3 in the formation and progression of human breast cancerPhosphorylation of estrogen receptor beta at serine 105 is associated with good prognosis in breast cancer.A role for estrogen receptor phosphorylation in the resistance to tamoxifen.p38γ mitogen-activated protein kinase (MAPK) confers breast cancer hormone sensitivity by switching estrogen receptor (ER) signaling from classical to nonclassical pathway via stimulating ER phosphorylation and c-Jun transcription.Estrogen signaling and cardiovascular disease.Structural and functional characterization of aromatase, estrogen receptor, and their genes in endocrine-responsive and -resistant breast cancer cells.Estrogen receptor-positive breast cancer: a multidisciplinary challenge.Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.Gray-Level Co-Occurrence Matrix Texture Analysis of Breast Tumor Images in Prognosis of Distant Metastasis Risk.The relationship between oestrogen receptor-alpha phosphorylation and the tumour microenvironment in patients with primary operable ductal breast cancer.MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells.Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition.FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells.Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer
P2860
Q30514241-61CA5AB2-0960-467A-AAD4-361CAB1D516CQ33960160-5D7050D5-E830-4C33-84D2-40EBC7E14065Q34086835-ECCF0999-44CF-4F77-8823-041FA51F3279Q35684445-683FB97A-ADBB-4783-82D5-A0461B2F6A79Q35922496-1E47AE7C-EDEB-4E99-A164-1173009773B3Q36099354-EAB23489-62DF-4DC1-BB46-FF21F7BD4537Q36578211-F22013DC-AE51-4069-A7DA-20DE821D8C0EQ37838375-042B983A-FA76-4570-8822-98F24B6BF336Q38028797-0464530F-3D5C-422F-A50C-6233F2D5852AQ39016042-BBAD95EA-643C-4A55-83D0-7A7839C065C1Q40270909-92B776D8-9C2E-4C0E-8917-07509A6C8E94Q40454863-C4E4D5EC-DC3C-499B-88DF-64C9BB47F6AFQ41660033-5C3064F2-7624-47A1-B228-6DF02BB6C80AQ42657804-814477BB-699E-4653-AFFA-824F411736D2Q46148692-CBED7CAB-8BF1-45FB-9386-74D49F8101FEQ50225023-13EAC00D-B3A3-4F10-86A1-3CFFF934504AQ58710004-116695B3-1569-42F5-8502-CF8F565EF41D
P2860
Estrogen receptor-alpha phosphorylation at serine-118 and tamoxifen response in breast cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Estrogen receptor-alpha phosph ...... fen response in breast cancer.
@en
Estrogen receptor-alpha phosph ...... fen response in breast cancer.
@nl
type
label
Estrogen receptor-alpha phosph ...... fen response in breast cancer.
@en
Estrogen receptor-alpha phosph ...... fen response in breast cancer.
@nl
prefLabel
Estrogen receptor-alpha phosph ...... fen response in breast cancer.
@en
Estrogen receptor-alpha phosph ...... fen response in breast cancer.
@nl
P2093
P2860
P356
P1476
Estrogen receptor-alpha phosph ...... fen response in breast cancer.
@en
P2093
Caroline Holm-Wigerup
Göran Landberg
Marleen Kok
Rob Michalides
Sabine Linn
P2860
P304
P356
10.1093/JNCI/DJP412
P407
P577
2009-12-01T00:00:00Z